Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation.
Lu W, Lyu H, Xiao X, Bai X, Zhang M, Wang J, Pu Y, Meng J, Zhang X, Zhu H, Yuan T, Wang B, Jin X, Cao X, Wang Z, Xie T, Meng H, Stepanov AV, Gabibov AG, An Y, Sun R, Zhang Y, Maschan MA, Zhu Z, Zhang H, Zhao M.
Lu W, et al. Among authors: sun r.
Leukemia. 2024 Apr 17. doi: 10.1038/s41375-024-02251-5. Online ahead of print.
Leukemia. 2024.
PMID: 38632315
No abstract available.